Common Contracts
5 similar Finance Contract contracts by CureVac B.V., Evaxion Biotech a/S, Immunic, Inc., Inventiva S.A.
INVENTIVA (EGFF) Finance Contract between the European Investment Bank and Inventiva S.A.Finance Contract • May 16th, 2022 • Inventiva S.A. • Pharmaceutical preparations
The European Investment Bank having its seat at 100 blvd Konrad Adenauer, Luxembourg, L-2950 Luxembourg, represented by Maria Teresa Massaad (Head of Division) and Antoine de Lachaux (Investment Officer) (the "Bank")
REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.Finance Contract • February 2nd, 2021
WHEREAS: 6 ARTICLE 1 7 1.1 INTERPRETATION 7 1.2 DEFINITIONS 7 ARTICLE 2 16 2.1 AMOUNT OF CREDIT 16 2.2 DISBURSEMENT PROCEDURE 16 2.2.1 TRANCHES 16 2.2.2 DISBURSEMENT OFFER 16 2.2.3 DISBURSEMENT ACCEPTANCE 17 2.3 DISBURSEMENT ACCOUNT 17 2.4 CURRENCY OF DISBURSEMENT 17 2.5 CONDITIONS OF DISBURSEMENT 17 2.5.1 INITIAL DOCUMENTARY CONDITIONS PRECEDENT 17 2.5.2 ALL TRANCHES - DOCUMENTARY CONDITIONS PRECEDENT 17 2.5.3 ALL TRANCHES–OTHER CONDITIONS 18 2.5.4 TRANCHE A–ADDITIONAL CONDITIONS PRECEDENT 18 2.5.5 TRANCHE B–ADDITIONAL CONDITIONS PRECEDENT 18 2.5.6 TRANCHE C–ADDITIONAL CONDITIONS PRECEDENT 18 2.6 CANCELLATION 19 2.7 FEE FOR CANCELLATION OF AN ACCEPTED TRANCHE 19 2.8 CANCELLATION AFTER EXPIRY OF THE CREDIT 19 2.9 DROP DEAD FEE 20 2.10 SUMS DUE UNDER ARTICLE 2 20 ARTICLE 3 20 3.1 AMOUNT OF LOAN 20 3.2 CURRENCY OF REPAYMENT, INTEREST AND OTHER CHARGES 20 ARTICLE 4 20 4.1 DEFERRED INTEREST FIXED RATE 20 4.2 VARIABLE REMUNERATION 20 4.3 INTEREST ON OVERDUE SUMS 22 ARTICLE 5 23 5.1 NORMAL R
ContractFinance Contract • January 8th, 2021 • Evaxion Biotech a/S • Biological products, (no disgnostic substances)
[****] This symbol identifies certain confidential information contained in this document that has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
REDACTEDFinance Contract • October 20th, 2020 • Immunic, Inc. • Pharmaceutical preparations
Certain identified information, indicated by [***], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.
REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.Finance Contract • July 31st, 2020 • CureVac B.V. • Pharmaceutical preparations
The European Investment Bank having its seat at 100 blvd Konrad Adenauer,Luxembourg, L-2950 Luxembourg, represented by Tero PIETILA, Head of Division and Ayse Nil ADA, Legal Counsel
